Press "Enter" to skip to content

New patent expiration for LILLY drug CIALIS

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for LILLY drug CIALIS

Annual Drug Patent Expirations for CIALIS
Annual Drug Patent Expirations for CIALIS

Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

CIALIS drug price trends.

Drug patent litigation for CIALIS.

The generic ingredient in CIALIS is tadalafil. Seven suppliers are listed for this compound. Additional details are available on the tadalafil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for LILLY drug CIALIS

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!